Substituted imidazole derivatives
The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
Novartis Vaccines and Diagnostics, Inc.
A A C C C C C A C C C C C C C C C C C C C C
A61P A61P C07D C07D C07D C07D C07D A61P C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Mark David Paul A. Eric Megan C. Savithri Yia Elisa Hong Elizabeth Rustum Kris Kay Kenneth W. Anu Kelly Sharadha Nathan Liana Marie Sabina Tinya Paul A. Vincent P. Ryan Rama Weibo Annette
Knapp Duhl Barsanti Martin Phillips Ramurthy Xia Jazan Yang Mieuli Boyce Mendenhall Huh Bair Sharma Wayman Subramanian Brammeier Lagniton Pecchi Abrams Renhowe Le Constantine Jain Wang Walter